Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03660943 · ClinicalTrials.gov registry record · Phase 3
A Clinical Study to Test Efficacy and Safety of Repeat Doses of CNTX-4975-05 in Patients With Osteoarthritis Knee Pain
A Phase 3 study of Osteoarthritis, Knee, sponsored by Centrexion Therapeutics.
- Completed
- Registry status
- Phase 3
- Development phase
- 332
- Enrollment target
- 20
- Study locations
NCT03660943 is a Phase 3 study of Osteoarthritis, Knee that has completed, run by Centrexion Therapeutics. The registered enrollment target is 332 participants, below the 576-participant average among 91 other Osteoarthritis, Knee trials with a reported enrollment target (42% lower). The trial reports 20 study locations across 9 states.
The verdict
NCT03660943, a Phase 3 study of Osteoarthritis, Knee, has completed, sponsored by Centrexion Therapeutics.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 332 participants
- Enrollment target
- 20
- Study locations
Study Summary
This is a randomized, double-blind, placebo-controlled, 2-injection, 52-week study to evaluate the efficacy and safety of intra-articular injections of CNTX-4975-05 in subjects with chronic, moderate-to-severe osteoarthritis knee pain.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG CNTX-4975-05
Study Locations (20)
Florida
- Panamerican Health Center, Inc. - Miami
- Well Pharma Medical Research, Corp - Miami
- Quality Research & Medical Center LLC - Miami
- San Marcus Research Clinic, Inc. - Miami Lakes
- Journey Research, Inc. - Oldsmar
- M&M Clinical Trials Sunrise - Sunrise
- Conquest Research - Winter Park
Arizona
- Holland Center for Family Health - Glendale
- GB Family Care - Phoenix
- Arizona Research Center - Phoenix
California
- Med Center Medical Clinic - Carmichael
- TriWest Research Associates - El Cajon
- Arthritis Care and Research Center, Inc. (ACRC Studies) - Poway
Illinois
- Healthcare Research Network, LLC - Flossmoor
- Affinity Clinical Research Institute - Oak Brook
Connecticut
- Chase Medical Research, LLC - Waterbury
Georgia
- Better Health Clinical Research, Inc. - Newnan
Louisiana
- DelRicht Research - New Orleans
Maryland
- The Center for Rheumatology and Bone Research - Wheaton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 332 participants |
| Start Date | 2018-09-09 |
| Est. Completion | 2020-06-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03660943
The ClinicalTrials.gov registry entry for NCT03660943 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 332 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 576-participant average among 91 other Osteoarthritis, Knee trials with a reported enrollment target (42% lower). The listed sponsor is Centrexion Therapeutics, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Osteoarthritis, Knee appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT03660943 reports 20 study locations spanning 9 distinct geographic areas - top geographies include Florida, Arizona, California.
Frequently Asked Questions
What is clinical trial NCT03660943 about?
NCT03660943 is a clinical study titled "A Clinical Study to Test Efficacy and Safety of Repeat Doses of CNTX-4975-05 in Patients With Osteoarthritis Knee Pain". This is a randomized, double-blind, placebo-controlled, 2-injection, 52-week study to evaluate the efficacy and safety of intra-articular injections of CNTX-4975-05 in subjects with chronic, moderate-to-severe osteoarthritis knee pain.
What is the current status of trial NCT03660943?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 332 participants. The study started on 2018-09-09. Estimated completion is 2020-06-11.
What conditions does trial NCT03660943 study?
This clinical trial studies the following conditions: Osteoarthritis, Knee.
What interventions are being tested in trial NCT03660943?
The interventions under investigation include: Placebo (DRUG), CNTX-4975-05 (DRUG).
Who is sponsoring clinical trial NCT03660943?
This trial is sponsored by Centrexion Therapeutics, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03660943 being conducted?
This trial has 20 study locations across Arizona, California, Connecticut, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis, Knee
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Investigate the Treatment Effect of Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Placebo in Adult Participants With Knee Osteoarthritis Pain.
RECRUITING · Phase 3
-
Rehabilitation for Arthritis of The Knee: mainTaining Improvement for Veterans
RECRUITING · Phase 3
-
A Study to Evaluate Efficacy and Safety of AMZ001 for the Treatment of Knee Osteoarthritis Symptoms
ACTIVE NOT RECRUITING · Phase 3
-
Autologous Adipose-derived Stromal Vascular Fraction for Treatment of Knee Osteoarthritis
ACTIVE NOT RECRUITING · Phase 3
-
A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight
ACTIVE NOT RECRUITING · Phase 3
-
Study to Evaluate the Effect of FX006 on Synovial Inflammation in Patients With OA of the Knee
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.